Pages that link to "Q53203255"
Jump to navigation
Jump to search
The following pages link to Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease. (Q53203255):
Displaying 27 items.
- Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer's disease (Q28214125) (← links)
- Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses (Q34045304) (← links)
- A non-invasive, rapid method to genotype late-onset Alzheimer's disease-related apolipoprotein E gene polymorphisms (Q34096343) (← links)
- Genetic susceptibility factors for Alzheimer's disease. (Q34134818) (← links)
- Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease. (Q35019451) (← links)
- The Association between Sporadic Alzheimer's Disease and the Human ABCA1 and APOE Gene Polymorphisms in Iranian Population (Q36022445) (← links)
- Overlap between neurodegenerative disorders (Q36117422) (← links)
- Association between Alzheimer's Disease and Apolipoprotein E Polymorphisms (Q36349173) (← links)
- Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease (Q36784564) (← links)
- Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid. (Q37155515) (← links)
- Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease (Q38481820) (← links)
- The toxicity in vitro of beta-amyloid protein (Q40422520) (← links)
- Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E (Q41221878) (← links)
- Sequence of Abeta-protein deposition in the human medial temporal lobe. (Q42492271) (← links)
- Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms. (Q43484059) (← links)
- Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation. (Q44251907) (← links)
- The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid (Q47625100) (← links)
- Initiation and propagation stages of beta-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles (Q47837030) (← links)
- DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease. (Q47838886) (← links)
- Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease (Q48390072) (← links)
- Prevalence, Incidence and Duration of Braak’s Stages in the General Population: Can We Know? (Q48662137) (← links)
- Apolipoprotein E, A beta-amyloid, and the molecular pathology of Alzheimer's disease. Therapeutic implications. (Q53215699) (← links)
- NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography. (Q53215966) (← links)
- The use of apolipoprotein E genotyping as a diagnostic test in suspected Alzheimer's disease. (Q53323913) (← links)
- Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. (Q53325111) (← links)
- Head injury, amyloid β and Alzheimer's disease (Q71803407) (← links)
- Apolipoprotein E ϵ4 and cerebral hemorrhage associated with amyloid angiopathy (Q72007219) (← links)